In another study, Fordham AM’s experiments using animal models of allotransplantation revealed that combining a CD30 inhibitor with ALKi resulted in significant tumor shrinkage in both diagnostic and relapse xenograft model groups (59). This evidence concerns the gene TNFRSF8 and neoplasm.